1. Home
  2. ESQ vs RGNX Comparison

ESQ vs RGNX Comparison

Compare ESQ & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESQ
  • RGNX
  • Stock Information
  • Founded
  • ESQ 2006
  • RGNX 2008
  • Country
  • ESQ United States
  • RGNX United States
  • Employees
  • ESQ N/A
  • RGNX N/A
  • Industry
  • ESQ Commercial Banks
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ESQ Finance
  • RGNX Health Care
  • Exchange
  • ESQ Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • ESQ 525.7M
  • RGNX 459.1M
  • IPO Year
  • ESQ 2017
  • RGNX 2015
  • Fundamental
  • Price
  • ESQ $63.23
  • RGNX $9.51
  • Analyst Decision
  • ESQ Buy
  • RGNX Strong Buy
  • Analyst Count
  • ESQ 4
  • RGNX 11
  • Target Price
  • ESQ $64.50
  • RGNX $37.70
  • AVG Volume (30 Days)
  • ESQ 25.7K
  • RGNX 516.0K
  • Earning Date
  • ESQ 10-29-2024
  • RGNX 11-06-2024
  • Dividend Yield
  • ESQ 0.95%
  • RGNX N/A
  • EPS Growth
  • ESQ 3.98
  • RGNX N/A
  • EPS
  • ESQ 4.79
  • RGNX N/A
  • Revenue
  • ESQ $112,338,000.00
  • RGNX $89,044,000.00
  • Revenue This Year
  • ESQ N/A
  • RGNX $9.24
  • Revenue Next Year
  • ESQ $12.80
  • RGNX $201.54
  • P/E Ratio
  • ESQ $13.32
  • RGNX N/A
  • Revenue Growth
  • ESQ 12.78
  • RGNX N/A
  • 52 Week Low
  • ESQ $43.85
  • RGNX $9.11
  • 52 Week High
  • ESQ $67.78
  • RGNX $28.80
  • Technical
  • Relative Strength Index (RSI)
  • ESQ 50.20
  • RGNX 42.53
  • Support Level
  • ESQ $60.95
  • RGNX $9.11
  • Resistance Level
  • ESQ $67.78
  • RGNX $11.23
  • Average True Range (ATR)
  • ESQ 1.49
  • RGNX 0.56
  • MACD
  • ESQ -0.00
  • RGNX 0.13
  • Stochastic Oscillator
  • ESQ 36.27
  • RGNX 38.68

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: